» Articles » PMID: 28131524

The Histopathologic Type Predicts Survival of Patients with Ampullary Carcinoma After Resection: A Meta-analysis

Overview
Journal Pancreatology
Date 2017 Jan 30
PMID 28131524
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The results of studies on the prognostic value of histopathologic differentiation of the intestinal and pancreatobiliary types of ampullary carcinoma after resection are conflicting. A meta-analysis was undertaken to investigate this issue.

Methods: A systematic literature search was performed to identify articles published from January 2000 to August 2016. Data were pooled for meta-analysis using Review Manager 5.3.

Results: Twenty three retrospective studies involving a total of 2234 patients were identified for inclusion, of whom 1021 (45.7%) had intestinal type tumors and 899 (40.2%) had pancreaticobiliary type tumors. Patients with the pancreaticobiliary type had high rates of poor tumor differentiation (P < 0.001), lymph node metastasis (P < 0.001), vascular invasion (P < 0.001), perineural invasion (P < 0.001), and positive resection margins (P = 0.004), as compared with those with the intestinal type. The pancreaticobiliary type predicted a worse overall survival (hazard ratio [HR] 1.84, 95% CI 1.49-2.27; P < 0.001) and disease-free survival (HR 1.93, 95% CI 1.23-3.01; P = 0.004).

Conclusion: The histopathologic type has major impact on survival in patients with ampullary carcinoma after resection, and the pancreaticobiliary type reflects a more aggressive tumor biology and is associated with worse survival.

Citing Articles

Nomogram for overall survival in ampullary adenocarcinoma using the surveillance, epidemiology, and end results database and external validation.

Yang J, Wang Z, Chen J, Zhang Y, Chen L World J Clin Oncol. 2025; 16(2):95910.

PMID: 39995566 PMC: 11686567. DOI: 10.5306/wjco.v16.i2.95910.


Prediction of tumor recurrence after surgical resection of ampullary adenocarcinoma using magnetic resonance imaging.

Lee S, Lee J, Kim K, Hwang J, Choi S, Moon J Eur Radiol. 2024; 34(10):6929-6939.

PMID: 38536460 DOI: 10.1007/s00330-024-10713-8.


Updates on the Management of Ampullary Neoplastic Lesions.

Maselli R, De Sire R, Fugazza A, Spadaccini M, Colombo M, Capogreco A Diagnostics (Basel). 2023; 13(19).

PMID: 37835881 PMC: 10572979. DOI: 10.3390/diagnostics13193138.


Ampullary Cancer: Histological Subtypes, Markers, and Clinical Behaviour-State of the Art and Perspectives.

Nappo G, Funel N, Laurenti V, Stenner E, Carrara S, Bozzarelli S Curr Oncol. 2023; 30(7):6996-7006.

PMID: 37504367 PMC: 10378042. DOI: 10.3390/curroncol30070507.


Ampulla of Vater carcinoma: advancement in the relationships between histological subtypes, molecular features, and clinical outcomes.

Liang H, Zhu Y, Wu Y Front Oncol. 2023; 13:1135324.

PMID: 37274233 PMC: 10233008. DOI: 10.3389/fonc.2023.1135324.